A comprehensive examination of patentability for an innovative pain relief formulation with unique ingredient combinations.
This case study examines Prior Art Analysis for patentability of a pain relief cream based on a prior art search and analysis. The study, titled "Patentability – Pain Relief Cream," investigates the novelty and non-obviousness of the cream's specific combination of ingredients.
The analysis revealed unique combinations of natural ingredients, particularly the inclusion of rare components, which were not found in prior art either individually or in combination for pain relief applications.
Scientific papers and market research
Existing pain relief creams in the market
Patent search across multiple jurisdictions
Analysis of 864 potentially relevant patent documents
Review of existing market products
Scientific literature review
Seven closest prior art documents identified
Six similar products analyzed
Key research papers reviewed, including specific studies on Daphne species
A feature matrix was created to illustrate the overlap between the "Pain Relief Cream" ingredients and those disclosed in the closest identified patent results. The matrix compares the presence of each ingredient in the Pain Relief Cream against several patents, including Wittmayer ( WO2023225143A1), Orie et al. (CN108883049B), Xin (CN115645504A), Marques et al. (BR102012016205A2), Jinke et al. (CN117224592A), Baptiste et al. (CN110149795B), and Chao (CN106852841A).
The matrix reveals that none of the identified patents disclose a combination of all the ingredients found in "Pain Relief Cream". For example, Wittmayer discloses some overlaping ingredients, but not the other ingredeints. Same is the case with other patents.

Novel formulation not found in prior art
Specific ingredients not suggested for pain relief
Distinctive formulation creates market advantage
The study argues that even if a person skilled in the art were to combine some of the ingredients, the combination of some of the Ingredeints in the client's Pain Relief Cream would not be obvious, as these ingredients are not suggested for pain relief composition. This specific combination is considered the unique selling point (USP) of the product.
The review of market products revealed that none use the specific ingredient set of "Pain Relief Cream." Instead, they use ingredients like Lidocaine, apricot/grape/hemp oils, etc., as active ingredients.
Research articles primarily discuss commonly known pain relief ingredients like clove, horse chestnut, and licorice. While Moshiashvili highlights the anti-inflammatory properties of different Daphne species, including one in client's formulation, no papers suggest using two main ingredeints from client's formulation for pain relief.
Confirmed – unique combination not found in prior art
Supported by the absence of suggestions to combine the specific ingredients
Clear application in pain relief sector
Showing no complete overlap with existing patents
Demonstrating distinct formulation from competitors
Supporting individual ingredient efficacy
Clear and comprehensive evaluation
Thorough prior art search
Identified and analyzed in detail
Competitive landscape assessment
Based on strong patentability assessment
Emphasize specific formulation details
Highlight rare components as key differentiators
Structured approach to finding relevant prior art
Multiple patent and literature databases searched
Patents, products, and literature examined
Detailed recording of all findings
Our analysis has identified several key strengths supporting this product's patentability potential.
Unique ingredient combination with novel components
Solid analysis base for patent application strategy
Novel product with strong patent protection potential
The Pain Relief Cream formulation stands out primarily due to its unique combination of ingredients not previously used together in pain relief compositions, creating a distinctive opportunity in the market.
Prior Art Analysis for a Unique Pain Relief Cream: A Detailed Case Study